The battle between two global majors vying for a larger pie of the Rs 628-crore Indian anti-obesity market is set to ...

The incidence of obesity and diabetes is rising in India, the world’s most populous country, which also ranks among the worst ...

There’s no such thing as 'natural Ozempic.' While supplements like psyllium, berberine, and glucomannan are paraded as ...

Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...

As weight-loss drugs like semaglutide and tirzepatide dominate global headlines, a new nationwide survey shows that 87 per ...

The drug is now available for prescription in New Zealand but there are clouds to go along with the silver linings - such as ...

Essex mother Camilla Do Rosario told her TikTok followers the one piece of advice she wishes she knew before embarking on a ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

A NEW study challenges the idea that weight loss jabs decrease muscle mass, alongside fat. Scientists say one injection – ...

Weight loss injections promise quick results, but skipping blood screening can trigger serious risks like pancreatitis or ...